Insight

Filippo Montemurro: Different dosage forms of hormone agonists in endocrine therapy

Photo of Filippo Montemurro taken from www.irccs.com

Oct 15, 2024, 13:10

Filippo Montemurro: Different dosage forms of hormone agonists in endocrine therapy

Filippo Montemurro, Senior Medical Director at F. Hoffmann La Roche, shared a post on X:

“Different dosage forms of gonadotropin-releasing hormone agonist with endocrine therapy in premenopausal hormone receptor-positive breast cancer. Monthly or three-monthly injections?”

Different dosage forms of gonadotropin-releasing hormone agonist with endocrine therapy in premenopausal hormone receptor-positive breast cancer

Authors: Jinna Lin, Yiye Ouyang, Yudong Li, Liang Jin, Shunying Li, Yujie Liu, Yaping Yang, Qianfeng Shi, Mengdi Zhu, Zijie Cai, Jingru Wang, Nianqiu Liu, Yue Hu, Zongqi Wu, Mengzi Wu, Lok Lam Wong, Xiaoting Jiang, Qi Wang, Wang Yang, Qiang Liu.

breast cancer treatment cancer cancer therapy clinical oncology dosage forms endocrine therapy F. Hoffmann La Roche Filippo Montemurro gonadotropin-releasing hormone healthcare professionals hormone receptor-positive breast cancer Jingru Wang Jinna Lin Liang Jin Lok Lam Wong Medical Research Mengdi Zhu Mengzi Wu Nianqiu Liu OncoDaily Oncology patient care Qi Wang Qianfeng Shi Qiang Liu Shunying Li Wang Yang Xiaoting Jiang Yaping Yang Yiye Ouyang Yudong Li Yue Hu Yujie Liu Zijie Cai Zongqi Wu

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Bispecific Antibody M701 Offers a Novel Treatment Option for Malignant Ascites

Special Coverage